U.S. Chemicals Stock News

PLAYSTUDIOS (MYPS) saw its losses accelerate at an average rate of 56.9% per year over the last five years, and the company remains unprofitable, with forecasts calling for continued losses through the next three years. Revenue is also projected to decline by 2.1% annually, adding further pressure on profit margins. Despite these tough numbers, MYPS trades at $0.82, a notable discount to its estimated fair value of $3.40. Valuation metrics stand out versus peers in the sector. See our full...

Energys Group (ENGS) has reported continued losses, with net losses growing at an average annual rate of 14.1% over the past five years. The company's Price-to-Sales Ratio stands at 17.5x, which is significantly above the industry average of 1.4x and the peer group’s 4.8x. With no concrete signs of margin improvement or profit growth in the recent data, investors currently face a situation defined by persistently elevated valuation multiples and a lack of positive earnings momentum. See our...

Exagen (XGN) is set to outpace the broader US market with revenue forecast to rise 11.7% per year, compared to the expected 10.5% market growth. Despite a persistent lack of profitability, the company has trimmed losses at an average annual rate of 4.7% over the past five years. The narrative is defined by rapid top-line expansion and shares trading at a 3.7x Price-to-Sales Ratio, which is below both the peer average of 6.5x and the sector’s 10.8x benchmark. The current share price of $10.77...

Wondering if Barrett Business Services could be a hidden value play or just another stock on your watchlist? Let’s dig into what really matters when sizing up its worth. After climbing a solid 8.4% over the past year and delivering an impressive 139.1% return in the last five years, the stock has recently cooled off, sliding 2.7% in the past week and 10.4% this past month. Shares have drifted in recent weeks as sector momentum faded and investors weighed mixed signals from broader labor...

Gaia (GAIA) remains in the red, recording unprofitable results with net losses worsening at an average annual rate of 48.7% over the past five years. Despite the ongoing losses, forecasts now point to rapid improvement, with earnings expected to grow by 95.93% per year and a return to profitability within three years. This would outpace most of the market. Meanwhile, revenue growth is set to reach 14.1% annually, which exceeds the predicted 10.5% average across the US market. At a trading...

Integral Ad Science Holding (IAS) posted current net profit margins of 7.9%, improving from 6.4% a year ago, while earnings grew 42.9% over the last twelve months. This is an impressive figure, though it remains below the robust five-year average growth rate of 73.5% per year. Looking ahead, analysts project revenue to rise at 10.1% per year and forecast significant earnings growth at 23.1% per year, both pointing to momentum outpacing much of the US market. With margins expanding and growth...

Anywhere Real Estate (HOUS) is currently unprofitable, with losses over the past five years growing at an annual rate of 18.2%. Shares are trading at $10.98, below the estimated fair value of $16.31 based on discounted cash flow analysis. Earnings are forecast to rebound sharply, with 128.7% annual EPS growth expected, and the company is projected to return to profitability within three years. However, revenue is only forecast to rise by 8.4% per year, which trails the broader US market’s...

Emergent BioSolutions recently reported third-quarter 2025 results, with revenue of US$231.1 million and net income of US$51.2 million, and raised its full-year 2025 guidance for both revenue and net income. The company's stronger-than-expected performance was supported by growth in NARCAN nasal spray, new U.S. government and international contracts, and a completed share repurchase program. We'll now examine how the company's upgraded full-year outlook and growth in core product lines may...

Driven Brands Holdings (DRVN) remains unprofitable, with losses accelerating at an average rate of 48.1% per year over the past five years. However, analysts expect earnings to grow by 56.02% annually, projecting the company will achieve profitability within the next three years. This outlook stands above market averages. Revenue is forecast to grow 4% per year, which is slower than the 10.5% US market average, but the company’s valuation continues to attract attention as shares trade well...

PotlatchDeltic (PCH) delivered a sharp turnaround in profitability this quarter, with its net profit margin climbing to 5.8%, up from just 1.6% a year ago, and earnings rising 288.4% year-over-year. This is far stronger than its five-year average, which saw earnings declining 38.9% per year. Looking ahead, the company is forecasting annual earnings growth of 17.9%, set to outpace the broader US market, while management values shares below their estimated fair value at $38.95. These improving...

Ever wondered if Alight could be a hidden gem or is already priced to perfection? If you’re on the hunt for value, you might be surprised by what the numbers reveal. It's been a rollercoaster for Alight’s shareholders. They have seen the stock drop 12.3% in the last week and a staggering 60.0% since the start of the year, signaling a big shift in how the market values the business. Recently, Alight made headlines by entering new partnerships that aim to strengthen its position in the...

Sealed Air Corporation recently reported third-quarter 2025 earnings, highlighting a substantial increase in net income to US$255.1 million and diluted earnings per share to US$1.73, compared to the same period last year, with sales remaining largely unchanged at US$1.35 billion. This performance suggests operational efficiencies are compensating for flat revenue, as the company also reaffirmed its full-year earnings guidance despite continued volume pressures in several segments. We’ll...

Curious if Hertz Global Holdings is a bargain or a bounce trap? You're not alone, and we're diving deep to see just how much value might be hiding in the numbers. The stock has rocketed up 32.4% year to date and gained an impressive 69.8% over the past year, even though it has dipped 4.4% in the last week and 21.0% over the past month. Momentum has largely been sparked by renewed attention on the used car market and shifting consumer travel habits, both of which put Hertz in the spotlight...

Heritage Insurance Holdings Inc will report its Q3 2025 earnings on November 5, 2025, following a quarter where its actual earnings per share significantly surpassed analyst expectations even as revenue came in below estimates. This divergence between stronger-than-expected earnings and softer revenue projections, alongside upward earnings estimate revisions and declining revenue forecasts for 2025 and 2026, has driven increased investor attention ahead of the upcoming results. We will...

Marathon Petroleum Corporation's ( NYSE:MPC ) periodic dividend will be increasing on the 10th of December to $1.00...

Pfizer Inc. ( NYSE:PFE ) stock is about to trade ex-dividend in 2 days. The ex-dividend date is one business day before...

The Plug Power Inc. ( NASDAQ:PLUG ) share price has softened a substantial 28% over the previous 30 days, handing back...

Twilio Inc. ( NYSE:TWLO ) shares have had a really impressive month, gaining 32% after a shaky period beforehand...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Spare a thought for...

In the current U.S. market landscape, major stock indexes have experienced a pullback, with tech shares leading the decline despite some companies posting strong quarterly results. Amidst this backdrop of fluctuating indices and economic uncertainty, identifying growth companies with high insider ownership can be crucial for investors seeking potential resilience and alignment of interests between management and shareholders.

Rani Therapeutics Holdings announced it would present preclinical data on its RaniPill® oral delivery platform at ObesityWeek® 2025, highlighting that oral semaglutide (RT-116) in dogs is bioequivalent to subcutaneous injections and produces similar weight loss. This research could generate interest, as it demonstrates the potential for the RaniPill to enable oral delivery of peptide drugs traditionally administered via injection. We'll examine how these promising preclinical results for...

Pacific Biosciences of California (PACB) shares jumped after news broke that ARK Investment Management, led by Cathie Wood, had acquired over one million shares. This high-profile buy is increasing investor attention and speculation around PacBio’s DNA sequencing technology and its growth outlook. See our latest analysis for Pacific Biosciences of California. ARK’s sizeable buy-in comes as PacBio’s share price has staged a sharp reversal. After months of drifting, the past 30 days saw a...

We feel now is a pretty good time to analyse Blend Labs, Inc.'s ( NYSE:BLND ) business as it appears the company may be...